Detalles de la búsqueda
1.
Apolipoprotein D modulates lipid mediators and osteopontin in an anti-inflammatory direction.
Inflamm Res
; 72(2): 263-280, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36536251
2.
Long-Term Treatment With Evolocumab Among Japanese Patientsã- Final Report of the OSLER Open-Label Extension Studies.
Circ J
; 83(5): 971-977, 2019 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30930429
3.
Pharmacokinetics and exploratory efficacy biomarkers of bococizumab, an anti-PCSK9 monoclonal antibody, in hypercholesterolemic Japanese subjectsâ©.
Int J Clin Pharmacol Ther
; 57(12): 575-589, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31549625
4.
Sitosterol prevents obesity-related chronic inflammation.
Biochim Biophys Acta Mol Cell Biol Lipids
; 1863(2): 191-198, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29221711
5.
Low-Density Lipoprotein Cholesterol Goal Attainment Rates by Initial Statin Monotherapy Among Patients With Dyslipidemia and High Cardiovascular Risk in Japanã- A Retrospective Database Analysis.
Circ J
; 82(6): 1605-1613, 2018 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29628458
6.
Efficacy and Safety of the Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib in Combination With Atorvastatin in Japanese Patients With Primary Hypercholesterolemia.
Circ J
; 82(1): 183-191, 2017 12 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28768921
7.
Efficacy and Safety of Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib Administered as Monotherapy in Japanese Patients With Primary Hypercholesterolemia.
Circ J
; 81(11): 1686-1692, 2017 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28652529
8.
Efficacy and Safety of Bococizumab (RN316/PF-04950615), a Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, in Hypercholesterolemic Japanese Subjects Receiving a Stable Dose of Atorvastatin or Treatment-Naiveã- Results From a Randomized, Placebo-Controlled, Dose-Ranging Study.
Circ J
; 81(10): 1496-1505, 2017 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28539539
9.
One-Year Efficacy and Safety of Evolocumab in Japanese Patientsã- A Pooled Analysis From the Open-Label Extension OSLER Studies.
Circ J
; 81(7): 1029-1035, 2017 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28367845
10.
Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale.
Lipids Health Dis
; 16(1): 121, 2017 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28623954
11.
Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project.
Stroke
; 47(6): 1605-11, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27165949
12.
Genome-wide association study of serum lipids confirms previously reported associations as well as new associations of common SNPs within PCSK7 gene with triglyceride.
J Hum Genet
; 61(5): 427-33, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26763881
13.
Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statinsã- ODYSSEY JAPAN Randomized Controlled Trial.
Circ J
; 80(9): 1980-7, 2016 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27452202
14.
Pitavastatin therapy in polymedicated patients is associated with a low risk of drug-drug interactions: analysis of real-world and phase 3 clinical trial data.
Int J Clin Pharmacol Ther
; 53(8): 635-46, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26104032
15.
Genotyping of Acinetobacter baumannii strains isolated at a Japanese hospital over five years using targeted next-generation sequencing.
J Infect Chemother
; 21(7): 512-5, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25862195
16.
Extending the "Lower is Better" Principle to Japanese and Possibly Other Asian Populations.
Circulation
; 137(19): 2010-2012, 2018 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29735588
17.
Effects of evolocumab (AMG 145), a monoclonal antibody to PCSK9, in hypercholesterolemic, statin-treated Japanese patients at high cardiovascular risk--primary results from the phase 2 YUKAWA study.
Circ J
; 78(5): 1073-82, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24662398
18.
Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: the OMEGA study risk factor sub-analysis.
Clin Exp Hypertens
; 36(4): 236-43, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-23865387
19.
Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
JAMA
; 312(23): 2510-20, 2014 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25401325
20.
The relationship between low-density lipoprotein cholesterol levels and the incidence of cardiovascular disease in high-risk patients treated with pravastatin: main results of the APPROACH-J study.
Int Heart J
; 55(1): 39-47, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24463915